Semi-annual Report for 2026
Filed with SSE · · 152 pages · Chinese
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Jiuzhou Pharmaceutical
- Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds and Continued Cash Management
- Announcement on Completion of Closure of Certain Special Accounts for Raised Funds from 2020 Non-public Issuance of Shares
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Completion of Industrial and Commercial Change Registration
- Announcement on Implementation of Canceling Partial Repurchased Shares
Later from Zhejiang Jiuzhou Pharmaceutical
- Announcement on Redemption upon Maturity of Cash Management Products Purchased with Certain Idle Raised Funds
- Announcement on Repurchasing Shares for Cancellation and Reduction of Registered Capital and Notification to Creditors
- Announcement on Using Idle Raised Funds for Cash Management
- Announcement on Adjustment of Upper Limit of Repurchase Price Following Implementation of Dividend Distribution for the First Half of 2026
- Notice on Convening the 3rd Extraordinary General Meeting in 2026
Follow Zhejiang Jiuzhou Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Jiuzhou Pharmaceutical